Newest first. 5.2k questions across 107 tags.
The lane and the lead time matter as much as the material for what I am doing. I would rather understand the derivation than memorise the outcome. Two people I asked…
Details up front: GL Biochem · Chinese Peptide Company. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for…
The specifics, since they change the answer: a 29G needle · ecnoglutide · 20 mg/mL. The comparison I want does not seem to exist anywhere in a form I can evaluate. I…
What I am working with: QYB · a residual-solvent screen. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that…
The specifics, since they change the answer: a 29G needle · 4 mg/mL. I would rather understand the derivation than memorise the outcome. Two people I asked gave two…
Setup, so nobody has to ask: a 25G drawing needle · 5 mg/mL. I have worked this out and I would like someone to find the error, because I suspect there is one. My…
Setup, so nobody has to ask: Wuhan · the United States. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
Concretely: dulaglutide · fourteen days. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What I…
What I am working with: 95.2% · sampling plan. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
What I have: Medutest · 99.1%. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the date, and I…
What I have: a GLP-1 receptor agonist · sixteen weeks · minus 20 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may…
The case in front of me: eGFR · orforglipron. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which…
Details up front: vomiting · tirzepatide · SURPASS-3. This is presented as though it settles something, and I am not convinced it does. I have two documents that…
Numbers first: a GLP-1 receptor agonist · a C8 column · survodutide. I have used one of these for a while and I am considering switching, which requires a reason.…
What I have: cagrilintide · a C8 column · mazdutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
The case in front of me: Qingdao · Poland. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
The case in front of me: FLOW · reflux · 1 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
The label documentation for the agent in question is ambiguous on exactly this point. This is one of those things that everyone repeats and nobody derives. This…
Setup, so nobody has to ask: TFC · SSA · the United Kingdom. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to…
My setup is a refrigerator with a logger and a small work area I wipe down, nothing more. I want to decide this in advance so that I am not deciding it under pressure…
Conditions: ecnoglutide · a C4 column · retatrutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
The case in front of me: hair thinning · tirzepatide · SURMOUNT-3. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
Concretely: aspartimide formation · tirzepatide · 25 °C. This is one of those things that everyone repeats and nobody derives. This matters practically, not just…
I have been through one internal appeal already and would like to do the next one properly. I have the document in front of me and I can read the numbers. What I…